시장보고서

상품코드

1401002

PEG화 단백질 시장 : 단백질 유형별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

PEGylated Proteins Market, By Protein Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: 2023년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 282 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

PEG화 단백질 시장 규모는 2022년에 144억 2,430만 달러로 평가되며, 2023-2030년 CAGR 4.7%로 확대할 것으로 예상됩니다.

PEG화 단백질 시장 - 시장 역학

생물학적 제제 치료에서 치료 효과와 환자 경험 개선의 필요성이 시장 수요를 촉진합니다.

PEG화는 약물의 체내 순환 증가, 면역원성 감소, 안정성 향상 등 다양한 장점이 있습니다. 이를 통해 투여 횟수를 줄일 수 있으며, 환자의 순응도를 높이고 만성질환 치료의 부담을 줄일 수 있습니다. 또한 PEG화는 부작용과 부작용을 감소시켜 생물학적 제제를 환자가 더 잘 견디고 안전하게 복용할 수 있도록 할 수 있습니다. 그 결과, 제약회사와 연구자들은 현재의 생물학적 제제를 최적화하고 혁신적인 치료법을 개발하기 위한 기술로 PEG화를 계속 연구하고 있으며, 궁극적으로 의료 결과를 개선하는 것을 목표로 하고 있습니다.

PEG화 단백질 시장 - 주요 인사이트

AnalystView Market Insights의 리서치 애널리스트의 분석에 따르면 세계 PEG화 단백질 시장은 예측 기간(2023-2030년) 동안 약 4.7%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

PEG화 단백질 산업은 생물학적 제제 치료에서 치료 효과와 환자 경험을 개선해야 할 필요성으로 인해 빠른 속도로 성장할 것으로 예상됩니다.

단백질 유형별 세분화에서는 콜로니 자극 인자가 2022년 가장 큰 시장 점유율을 차지할 것으로 예상했습니다.

용도별로는 자가면역질환이 2022년 주요 단백질 유형으로 꼽혔습니다.

지역별로는 북미가 2022년 매출에서 선두를 달리고 있습니다.

PEG화 단백질 시장 - 세분화 분석 :

PEG화 단백질 세계 시장은 단백질 유형, 용도, 최종 용도 및 지역에 따라 세분화됩니다.

시장은 단백질 유형에 따라 콜로니 자극 인자, 인터페론, 에리스로포이에틴, 기타 등 네 가지 범주로 나뉩니다. 콜로니 자극 인자는 시장을 독점하고 있으며, PEG화 단백질, 특히 PEG화 콜로니 자극 인자는 다양한 의약 용도에서 사용하기 때문에 수요가 높습니다. 혈액 세포 생성을 증가시키는 콜로니 자극 인자는 암, 빈혈, 면역 결핍증과 같은 질병의 치료 효과를 향상시키기 위해 PEG화되는 경우가 많습니다.

시장은 용도에 따라 암, 자가면역질환, 간염, 다발성 경화증, 혈우병, 소화기 질환, 기타로 나뉩니다. 자가면역질환 분야가 시장을 지배하고 있으며, 예측 기간 중에도 그 우위를 유지할 것으로 예상되며, PEG화 단백질은 자가면역질환에 대한 수요가 높습니다. 이러한 생물학적 제제는 폴리에틸렌글리콜(PEG)을 사용하여 자가면역 관련 단백질을 변화시켜 면역 반응을 조절하고 염증을 감소시킴으로써 류마티스 관절염, 다발성 경화증, 루푸스 등의 질환 치료에 반감기를 연장하고 효능을 향상시킬 수 있습니다. 치료 효과를 향상시킬 수 있습니다.

PEG화된 단백질 시장 - 지역적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다. 북미 PEG화 단백질 시장에는 여러 가지 변수가 영향을 미치고 있습니다. 이 지역은 혁신적인 생물학적 의약품의 개발 및 상용화에 전념하는 탄탄한 제약 및 생명공학 부문을 보유하고 있습니다. 또한 암, 자가면역질환, 혈액질환과 같은 만성질환의 빈도가 증가함에 따라 맞춤형 생물학적 치료제에 대한 수요가 증가하고 있습니다. 또한 북미의 규제 프레임워크는 기술 혁신을 촉진하고 PEG화 단백질과 같은 혁신적인 의약품 개발을 촉진하여 치료 효과와 환자 순응도를 향상시키고 있습니다. 마지막으로, 이 지역의 강력한 의료 및 인프라, 최첨단 치료법의 가용성은 PEG화 단백질 치료제를 위한 좋은 시장이며, 이 분야에 대한 지속적인 연구와 투자에 박차를 가하고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 : PEG화 단백질 산업

경쟁 대시보드
기업 개요
- Biogen Inc
- Pfizer Inc
- UCB SA
- Leadiant Biosciences, Inc.
- Amgen Inc.
- Thermo Fisher Scientific Inc.
- Horizon Therapeutics Plc.
- Novo Nordisk A/S
- F. Hoffmann-La Roche AG
- Bayer AG
- BioMarin
- RedHill Biopharma Ltd.
- Profacgen
- Creative PEGworks
- NOF America Corp.
- Aurigene Pharmaceutical Services Ltd.
- Laysan Bio, Inc.

제12장 애널리스트의 전방위 전망

KSA 24.01.09

REPORT HIGHLIGHT

PEGylated Proteins Market size was valued at USD 14,424.3 Million in 2022, expanding at a CAGR of 4.7 % from 2023 to 2030.

Therapeutic biologics or molecules that were chemically changed by the addition of polyethylene glycol (PEG) chains are referred to as PEGylated proteins. This change is intended to improve the biologic's pharmacokinetic features, such as enhanced stability, longer bloodstream circulation duration, and decreased immunogenicity. PEGylation increases medication bioavailability, allowing for less frequent dosage and perhaps decreasing adverse effects. This technology is frequently utilized in the pharmaceutical industry to enhance the therapeutic profile of different biologics, such as proteins and peptides, making them more successful in the treatment of a variety of medical disorders such as cancer, autoimmune diseases, and hemophilia.

PEGylated Proteins Market- Market Dynamics

The need to enhance the therapeutic efficacy and patient experience in biologic drug treatments propel market demand

PEGylation has various benefits, including increased medication circulation throughout the body, less immunogenicity, and greater stability. This enables less frequent dosage, which may improve patient compliance and reduce the burden of chronic illness care. Furthermore, PEGylation has the potential to reduce side effects and adverse responses, making biologics more bearable and safer for patients. As a consequence, pharmaceutical firms and academics are continuing to investigate PEGylation as a technique for optimizing current biologics and developing innovative therapies, with the goal of eventually improving healthcare outcomes.

PEGylated Proteins Market- Key Insights

As per the analysis shared by our research analyst, the global PEGylated Proteins market is estimated to grow annually at a CAGR of around 4.7% over the forecast period (2023-2030)

The PEGylated Proteins industry is projected to grow at a significant rate due to the need to enhance the therapeutic efficacy and patient experience in biologic drug treatments.

Based on Protein Type segmentation, Colony-stimulating Factors was predicted to show maximum market share in the year 2022

Based on Application segmentation, Autoimmune Diseases was the leading Protein Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

PEGylated Proteins Market- Segmentation Analysis:

The Global PEGylated Proteins Market is segmented on the basis of Protein Type, Application, End-Use, and Region.

The market is divided into four categories based on Protein Type: Colony-stimulating Factors, Interferons, Erythropoietin, and Others. The Colony-stimulating Factors dominates the market. PEGylated proteins, especially PEGylated colony-stimulating factors, are in high demand due to their usage in a variety of medicinal applications. Colony-stimulating factors, which increase the creation of blood cells, are often PEGylated to improve their therapeutic effectiveness in illnesses such as cancer, anaemia, and immunodeficiency disorders.

The market is divided into three categories based on Application: Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders, and Others. The Autoimmune Diseases sector dominates the market and is likely to maintain its dominance during the forecast period. PEGylated proteins are in high demand for use in autoimmune disorders. These biologics may provide prolonged half-lives and enhanced efficacy in treating illnesses such as rheumatoid arthritis, multiple sclerosis, and lupus by modulating immune responses and lowering inflammation by altering autoimmune-related proteins using polyethylene glycol (PEG).

PEGylated Proteins Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables influence the market for PEGylated proteins in North America. The area boasts a well-established pharmaceutical and biotechnology sector devoted to the development and commercialization of innovative biologic medicines. Additionally, the increasing frequency of chronic illnesses such as cancer, autoimmune disorders, and blood disorders has boosted the need for tailored biologic therapies. Furthermore, the regulatory framework in North America fosters innovation and the development of innovative medicine formulations, such as PEGylated proteins, which enhance treatment results and patient compliance. Finally, the region's strong healthcare infrastructure and availability of cutting-edge therapies make it a good market for PEGylated protein therapeutics, fueling continuous research and investment in this sector.

PEGylated Proteins Market- Competitive Landscape:

The competitive environment for PEGylated proteins is dynamic and varied. Leading pharmaceutical and biotechnology firms such as Roche, Amgen, and Novo Nordisk have made significant investments in the development of PEGylated biologics such as monoclonal antibodies and cytokines. However, there are also creative startups and specialized biotech corporations in the sector, such as Nektar Therapeutics, which focuses only on PEGylation technology. This variety encourages innovation and competitiveness, pushing for breakthroughs in drug delivery and increasing biologics' therapeutic profile. The competitive environment continues to change as the need for focused and long-lasting biologic medicines develops, with an emphasis on producing more effective and patient-friendly PEGylated protein therapeutics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PEGYLATED PROTEINS MARKET KEY PLAYERS

Biogen Inc
Pfizer Inc
UCB S.A.
Leadiant Biosciences, Inc.
Amgen Inc.
Thermo Fisher Scientific Inc.
Horizon Therapeutics Plc.
Novo Nordisk A/S
F. Hoffmann-La Roche AG
Bayer AG
BioMarin
RedHill Biopharma Ltd.
Profacgen
Creative PEGworks
NOF America Corp.
Aurigene Pharmaceutical Services Ltd.
Laysan Bio, Inc.

GLOBAL PEGYLATED PROTEINS MARKET, BY PROTEIN TYPE

Colony-stimulating Factors
Interferons
Erythropoietin
Others

GLOBAL PEGYLATED PROTEINS MARKET, BY APPLICATION

Cancer
Autoimmune Diseases
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorders
Others

GLOBAL PEGYLATED PROTEINS MARKET, BY END-USE

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutes

GLOBAL PEGYLATED PROTEINS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. PEGylated Proteins Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. PEGylated Proteins Market Snippet by Protein Type
- 2.1.2. PEGylated Proteins Market Snippet by Application
- 2.1.3. PEGylated Proteins Market Snippet by End-Use
- 2.1.4. PEGylated Proteins Market Snippet by Country
- 2.1.5. PEGylated Proteins Market Snippet by Region
2.2. Competitive Insights

3. PEGylated Proteins Key Market Trends

3.1. PEGylated Proteins Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. PEGylated Proteins Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. PEGylated Proteins Market Opportunities
3.4. PEGylated Proteins Market Future Trends

4. PEGylated Proteins Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. PEGylated Proteins Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. PEGylated Proteins Market Landscape

6.1. PEGylated Proteins Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. PEGylated Proteins Market - By Protein Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Protein Type, 2022 & 2030 (%)
- 7.1.2. Colony-stimulating Factors
- 7.1.3. Interferons
- 7.1.4. Erythropoietin
- 7.1.5. Others

8. PEGylated Proteins Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Cancer
- 8.1.3. Autoimmune Diseases
- 8.1.4. Hepatitis
- 8.1.5. Multiple Sclerosis
- 8.1.6. Hemophilia
- 8.1.7. Gastrointestinal Disorders
- 8.1.8. Others

9. PEGylated Proteins Market - By End-Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-Use, 2022 & 2030 (%)
- 9.1.2. Pharmaceutical & Biotechnology Companies
- 9.1.3. Contract Research Organizations
- 9.1.4. Academic & Research Institutes

10. PEGylated Proteins Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. PEGylated Proteins Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. PEGylated Proteins Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. PEGylated Proteins Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. PEGylated Proteins Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. PEGylated Proteins Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- PEGylated Proteins Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Biogen Inc
- 11.2.2. Pfizer Inc
- 11.2.3. UCB S.A.
- 11.2.4. Leadiant Biosciences, Inc.
- 11.2.5. Amgen Inc.
- 11.2.6. Thermo Fisher Scientific Inc.
- 11.2.7. Horizon Therapeutics Plc.
- 11.2.8. Novo Nordisk A/S
- 11.2.9. F. Hoffmann-La Roche AG
- 11.2.10. Bayer AG
- 11.2.11. BioMarin
- 11.2.12. RedHill Biopharma Ltd.
- 11.2.13. Profacgen
- 11.2.14. Creative PEGworks
- 11.2.15. NOF America Corp.
- 11.2.16. Aurigene Pharmaceutical Services Ltd.
- 11.2.17. Laysan Bio, Inc.

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us